New: NCI-funded clinical trial search
Mednet Logo

How are you integrating Prostox into your practice for prostate patients deciding between SBRT and hypofractionation?

3 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of New Mexico School of Medicine
Answered on

It has been my experience that 5-10% of prostate cancer patients undergoing SBRT can have prolonged irritative urinary symptoms that last 6 months to a year or longer. This appears significantly worse than with conventional or hypo-fractionated radiotherapy. It is reminiscent of permanent seed brach...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · NGPG Radiation Oncology
Answered on

I've offered it to the more savvy patients, especially those strongly interested in SBRT. It is a lot to review stage/ risk group AND all the fractionation options (I offer CFRT, MHRT, SBRT, HDR brachy monotherapy, HDR boosts depending on the patient) AND compare RT to surgery AND talk about ADT (as...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Fort Bend Medical and Diagnostic Center
Answered on

Curious how people are using this test?

Join for free or sign in to see the full answer